InflaRx N.V.
InflaRx N.V. (IFRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IFRX · as of Jun 9, 2026
Key Statistics
Explore InflaRx N.V. Data
ifrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 81.3%
The IFRX analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +426.32% upside from the current price of $1.71.
Competitors & Peers
ifrx competitorsIFRX
ARTV
ATYR
CNTB
CNTX
IMAStock Performance
Full HistoryAbout InflaRx N.V.
InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The co…
what is inflarx n.v. · ifrx stock overview · inflarx n.v. company profile · who is inflarx n.v. ceo · ifrx NASDAQ · inflarx n.v. headquarters · inflarx n.v. business segments
About Stock Overview & Key Data
InflaRx N.V. (IFRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 7, 2017. As of the latest trading session, IFRX stock price is $1.71, with a market capitalization of $123.5M. The stock has returned +101.18% over the past 12 months and +69.31% year-to-date.
According to 16 Wall Street analysts, the consensus rating for InflaRx N.V. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, InflaRx N.V. reported revenue of $29331.00 and net income of -$45.6M. For detailed data — including InflaRx N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, InflaRx N.V. (IFRX) stock price is $1.71. The stock is traded on NASDAQ under the ticker symbol IFRX. The 52-week range is $0.74 – $2.95.